NYU Langone Health researchers are seeking to analyze video recordings of sleep-related febrile seizures in living children to better understand these seizures and improve clinical care. Febrile ...

For pediatric kids aged two to five with seizure clusters, Aquestive Therapeutics (AQST, Financials) said that the U.S. Food and Drug Administration has given seven years of orphan drug ...

(RTTNews) - Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on delivering innovative medicines, announced that the FDA has granted Orphan Drug Exclusivity to Libervant ...

Free, Open Source tools to Alert Carers if someone suffers an Epileptic Seizure ...

Libervant received FDA approval for this pediatric age group on April 26, 2024, marking it as the first and only orally administered rescue therapy for seizure clusters in these patients.

The Sudden Unexplained Death in Childhood Registry and Research Collaborative (SUDCRRC) at NYU Langone has published several ...

For pediatric kids aged two to five with seizure clusters, Aquestive Therapeutics (AQST, Financials) said that the U.S. Food and Drug Administration has given seven years of orphan drug exclusivity to ...

Either 500 or 1000 mg twice daily of levetiracetam as an add-on therapy was used in 324 patients with uncontrolled simple or complex partial seizures ... problem in pediatric and adult populations.

Libervant received FDA approval for this pediatric age group on April 26, 2024, marking it as the first and only orally administered rescue therapy for seizure clusters in these patients. Daniel ...

Libervant received FDA approval for this pediatric age group on April 26, 2024, marking it as the first and only orally administered rescue therapy for seizure clusters in these patients. Daniel ...